279 related articles for article (PubMed ID: 19441904)
1. Sirtuin inhibitors.
Alcaín FJ; Villalba JM
Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
[TBL] [Abstract][Full Text] [Related]
2. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
3. DBC1 is a negative regulator of SIRT1.
Kim JE; Chen J; Lou Z
Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
[TBL] [Abstract][Full Text] [Related]
4. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation.
Kume S; Haneda M; Kanasaki K; Sugimoto T; Araki S; Isono M; Isshiki K; Uzu T; Kashiwagi A; Koya D
Free Radic Biol Med; 2006 Jun; 40(12):2175-82. PubMed ID: 16785031
[TBL] [Abstract][Full Text] [Related]
5. SIRTUIN 1: regulating the regulator.
Zschoernig B; Mahlknecht U
Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
[TBL] [Abstract][Full Text] [Related]
6. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.
Wang C; Chen L; Hou X; Li Z; Kabra N; Ma Y; Nemoto S; Finkel T; Gu W; Cress WD; Chen J
Nat Cell Biol; 2006 Sep; 8(9):1025-31. PubMed ID: 16892051
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
[TBL] [Abstract][Full Text] [Related]
8. The Sirtuin family: therapeutic targets to treat diseases of aging.
Milne JC; Denu JM
Curr Opin Chem Biol; 2008 Feb; 12(1):11-7. PubMed ID: 18282481
[TBL] [Abstract][Full Text] [Related]
9. Function of the SIRT1 protein deacetylase in cancer.
Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
[TBL] [Abstract][Full Text] [Related]
10. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.
Ford J; Jiang M; Milner J
Cancer Res; 2005 Nov; 65(22):10457-63. PubMed ID: 16288037
[TBL] [Abstract][Full Text] [Related]
11. Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.
Mai A; Valente S; Meade S; Carafa V; Tardugno M; Nebbioso A; Galmozzi A; Mitro N; De Fabiani E; Altucci L; Kazantsev A
J Med Chem; 2009 Sep; 52(17):5496-504. PubMed ID: 19663498
[TBL] [Abstract][Full Text] [Related]
12. Sirtuins and p53.
van Leeuwen I; Lain S
Adv Cancer Res; 2009; 102():171-95. PubMed ID: 19595309
[TBL] [Abstract][Full Text] [Related]
13. [Sirtuins--modulation of their activity as a novel therapeutic target].
Kucińska M; Piotrowska H; Murias M
Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.
Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S
Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of activators and inhibitors of sirtuins.
Balcerczyk A; Pirola L
Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.
Outeiro TF; Kontopoulos E; Altmann SM; Kufareva I; Strathearn KE; Amore AM; Volk CB; Maxwell MM; Rochet JC; McLean PJ; Young AB; Abagyan R; Feany MB; Hyman BT; Kazantsev AG
Science; 2007 Jul; 317(5837):516-9. PubMed ID: 17588900
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
18. Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells.
Matsushita N; Takami Y; Kimura M; Tachiiri S; Ishiai M; Nakayama T; Takata M
Genes Cells; 2005 Apr; 10(4):321-32. PubMed ID: 15773895
[TBL] [Abstract][Full Text] [Related]
19. Sirt1 modulates premature senescence-like phenotype in human endothelial cells.
Ota H; Akishita M; Eto M; Iijima K; Kaneki M; Ouchi Y
J Mol Cell Cardiol; 2007 Nov; 43(5):571-9. PubMed ID: 17916362
[TBL] [Abstract][Full Text] [Related]
20. The critical role of the class III histone deacetylase SIRT1 in cancer.
Liu T; Liu PY; Marshall GM
Cancer Res; 2009 Mar; 69(5):1702-5. PubMed ID: 19244112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
